Moroccan Insulin Maker Seeks Extension of Anti-Dumping Measures Against Danish Rival

The measure expiring in October 2019, the Moroccan manufacturer has filed a request with the Ministry of Industry and Trade for the renewal of the anti-dumping shield.

This approach reflects the Moroccan industrialist’s fear of reliving a similar scenario to that of 2012. But what is it exactly about? According to the Managing Director of Sothema Laboratory, the request aims to safeguard the national production of insulin and to stabilize the domestic market, by ensuring a regular and permanent supply.

The Danish manufacturer, whose distributor is none other than the Laprophan Laboratories, is said to be imposing competitive prices on Moroccan industrialists, allowing it to capture the national public procurement market.

The price reduction policy allows the Danish giant to put pressure on local industries and to take advantage of the acquired monopoly to multiply its prices and impose its law on the market. Brazil had had a similar experience with Novonordisk, swear its detractors.